Eli Lilly is developing tirzepatide for the treatment of type 2 diabetes mellitus (T2DM), obesity, cardiovascular disorders in T2DM, heart failure, non-alcoholic steatohepatitis, obstructive sleep apnoea and for reducing mortality/morbidity in obesity
The 'C' originally referred to choline but is now used interchangeably to mean the combined formula
Do not inject quickly
Moreover, NAD+ infusions may improve athletic endurance and reverse the symptoms of chronic fatigue
Here are some practical tips and recommendations: Practical Tips for Mitigating Skin Reactions Hydrate Your Skin Keeping your skin well-hydrated can help reduce dryness and irritation
Quick Answer: Lightheadedness on tirzepatide typically results from dehydration due to gastrointestinal side effects, hypoglycemia when combined with insulin or sulfonylureas, medication interactions affecting blood pressure, or orthostatic hypotension from weight loss